We previously found that a dose 5FU followed by three infusions of p50‐IMC slows the growth of syngeneic murine prostate cancer and pancreatic ductal carcinoma, whereas neither 5FU nor p50‐IMC alone were effective [17]. The gene discussed is NFKB1; the disease is pancreatic ductal adenocarcinoma.